ATS 2024 Final Program

Click on the session title to view the speakers

305

TUESDAY • MAY 21

522 Former U.S. Coal Miners Participating in Black Lung Clinics Have High Prevalence of Obstructive Lung Disease and Impairment, Particularly in Central Appalachia 523 Quantitative Chest CT-defined Structure and Pulmonary Function Among US Veterans Deployed to Afghanistan and Iraq 524 Longitudinal Comparison of Multiple Breath Washout Testing and Spirometry in Veterans With Deployment-related Respiratory Diseases and Healthy Controls 525 Analysis of Spatial Access to Computer-assisted, Image-guided Navigational Bronchoscopy Using Enhanced Two-step Floating Catchment Area Method

1008 Cellular Mechanisms Underlying the Pathogenetic Role of the Primary Cilium in Pulmonary Arterial Hypertension 1009 Chloride Ion Channel-1 Activation Is a Critical Mediator in the Pathogenesis of Hemolysis Induced Pulmonary Hypertension 1010 Classical Dendritic Cells Contribute to Shaping T Cell Responses in Hypoxia-induced Pulmonary Hypertension 1011 Successive Left Ventricular Overload and Unloading Reveals Mechanisms of Physiological Reverse Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease 1012 Cytopathic Tau Originating in Lung Capillaries Impairs Hippocampal Long-term Potentiation Following Bacterial Pneumonia 1013 Cathepsin-D: A Novel Paracrine Signal Driving Proliferation of Pulmonary Vascular Cells During Development of Chronic Obstructive Pulmonary Disease (COPD)-Associated Pulmonary Hypertension (PH) 1014 Causal Effects of Gut Microbiota on Pulmonary Arterial Hypertension 1015 Overexpression of EC-SOD Attenuates Hypoxia-induced Platelet Activation 1016 Hyperactive Mechanistic Target of Rapamycin Signaling Induces Endothelial Dysfunction and Pulmonary Vascular Remodeling 1017 Targeting Inflammation in Pulmonary Artery Hypertension: A High-throughput Small Molecule Screen for Compounds Degrading Xeroderma Pigmentosum Group B Protein (XPB) 1018 Dissecting the Lung Transcriptome of Pulmonary Fibrosis-associated Pulmonary Hypertension 1019 A Single-cell Census of Pulmonary Endarterectomies Tissue Across Different Anatomical Regions in Chronic Thromboembolic Pulmonary Hypertension 1020 The Impact of Pulmonary Hypertension on Neuroinflammation and Neurodegeneration in Murine Models 1021 Activation of the Mitochondrial Unfolded Protein Response (UPRM™) Promotes Vascular Remodeling in Pulmonary Arterial Hypertension

BASIC • TRANSLATIONAL POSTER DISCUSSION SESSION

C106 CORONADO BRIDGE: LINKING

NOVEL EXTRA-THORACIC DISEASE MECHANISMS WITH PAH

2:15 p.m. - 4:15 p.m.

San Diego Convention Center Room 6E (Upper Level)

Poster Viewing

2:15-3:00

Discussion 3:00-4:15 1001 Neuroinflammation Mediates Cognitive Dysfunction in Pulmonary Hypertension 1002 Male Specific Rage- T - Cell Axis in Inflammatory Pulmonary Arterial Hypertension Phenotype 1003 STING-mediated PD-L1 in Pulmonary Hypertension 1004 A Novel Gut-lung Axis in 15-HETE Diet-induced Pulmonary Hypertension 1005 Plasma Proteomics Identifies Beta-2-microglobulin (B2M) as a Regulator of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction 1006 Selective Deletion of the Natural Killer Cell Type II Transforming Growth Factor-ß (TGF-ß) Receptor Impairs Murine Lung Development and Function 1007 “Now I Lay Me Down To Sleep”: Circadian Dysrhythmia Is Associated With Poor Outcomes in Patients With Pulmonary Hypertension

ATS 2024 Conference Program • San Diego, CA